Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.57 | -5.19 | -7.28 | 8.57 | 26.35 | 3.78 |
PEG Ratio | 0.27 | -0.31 | 0.05 | 1.70 | -0.34 | 0 |
PS Ratio | 2.54 | 2.90 | 2.99 | 2.13 | 6.02 | 9.54 |
PB Ratio | 2.22 | 2.31 | 2.07 | 3.45 | 15.24 | 30.63 |
P/FCF Ratio | -6.67 | -33.87 | 14.24 | 3.63 | 13.60 | 21.38 |
P/OCF Ratio | -8.19 | 100.68 | 6.85 | 3.51 | 13.05 | 17.81 |
OCF/S Ratio | -31 | 2.88 | 43.68 | 60.70 | 46.12 | 53.57 |
Debt / Equity Ratio | 0.17 | 1.16 | 1.47 | 1.07 | 1.82 | 6.67 |
Quick Ratio | 5.69 | 6.65 | 7.41 | 7.31 | 7.34 | 2.28 |
Current Ratio | 6.60 | 7.53 | 8 | 7.70 | 7.89 | 2.54 |
Asset Turnover | 0.24 | 0.26 | 0.19 | 0.39 | 0.42 | 0.22 |
Interest Coverage | -0.25 | -4.94 | -0.69 | 28.13 | 18.33 | 3.90 |
Return on Equity | -61.58% | -44.53% | -28.56% | 40.39% | 57.70% | 86.87% |
Return on Assets | -16.97% | -14.37% | -8% | 9.65% | 9.49% | 6.05% |
Return on Invested Capital | -0.91% | -24.24% | 0.50% | 23.39% | 26.73% | 10.09% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 17.98% | 41.79% | 48.52% | 80.87% | 82.41% | 71.96% |
Net Profit Margin | -70.41% | -55.89% | -41.19% | 24.94% | 22.78% | 27.06% |
Pretax Profit Margin | -126.50% | -100.89% | 213.79% | 62.45% | 66.41% | 28.76% |
Operating Profit Margin | -3.63% | -90.91% | -10.95% | 65.03% | 69.40% | 42.20% |
FCF Margin | -38.08% | -8.56% | 21% | 58.76% | 44.26% | 44.63% |
EBITDA Margin | -79.20% | -60.54% | 246.56% | 69.08% | 73.29% | 48.67% |
Add to Watchlist
Select watchlists to add or remove MRVI